Tag: psychiatric medication of children
The time has come that the fictitious ADHD qualifies for my ‘Enough is Enough’ series. It’s time to stop addressing pharmaceutical psychiatry on its own terms: its fraudulent and corrupt 'science,' its spurious 'evidence base,' and its imaginary psychiatric ‘diseases.’ I’m done with this. The evidence is in. Let’s get real. Psychiatry has become a profession of drug pushers. As a psychiatrist I am beyond troubled. Let’s get real.
The general theme, that various "mental illnesses" are being "overdiagnosed" is gaining popularity in recent years among some psychiatrists, presumably in an effort to distance themselves from the trend of psychiatric-drugs-on-demand-for-every-conceivable-human-problem that has become an escalating and undeniable feature of American psychiatric practice. But the implicit assumptions – that there is a correct level of such labeling, and that the label has some valid ontological significance – are emphatically false.
At the risk of stating the obvious, ADHD is not an illness. Rather, it is an unreliable and disempowering label for a loose collection of arbitrarily chosen and vaguely defined behaviors. ADHD has been avidly promoted as an illness by pharma-psychiatry for the purpose of selling stimulant drugs. In which endeavor, they have been phenomenally successful, but, as in other areas of psychiatry, the hoax is unraveling.
The Sydney Morning Herald reports that, three years into an Australian study that is following 178 children with ADHD and 212 children without ADHD, the...
A Sydney, Australia law firm has launched a class action on behalf of people who as children and adolescents were prescribed Glaxosmithkline's drug Paroxetine. Despite...
The future of mental health interview series continued this past week with interviews with Peter Kinderman, president-elect of the British Psychological Society, on the efforts of the British Psychological Society, Jed Diamond on individual psychotherapy, Ruth Folit on healing through journaling, Shawn Rubin on gender diversity issues, and Marilyn Wedge on reclaiming childhood.
By 2002 GlaxoSmithKline had done 3 studies in children who were depressed and described all three to FDA as negative. As an old post on Bob Fiddaman’s blog reproduced here outlines, several years later they undertook another study in children in Japan. (Editor's note: This is a re-print, by David Healy, of a post by Bob Fiddaman)